These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Long-term platelet production assessed in NOD/SCID mice injected with cord blood CD34+ cells, thrombopoietin-amplified in clinical grade serum-free culture. Mattia G; Milazzo L; Vulcano F; Pascuccio M; Macioce G; Hassan HJ; Giampaolo A Exp Hematol; 2008 Feb; 36(2):244-52. PubMed ID: 18023520 [TBL] [Abstract][Full Text] [Related]
9. [Effects of selective cyclooxygenase-2 inhibitor NS-398 on 5-fluorouracil chemotherapy and progression of colon cells: an experimental study]. Zhang YC; Wang S; Zhang H; Ye YJ; Liang B; Cui ZR Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):583-6. PubMed ID: 15144595 [TBL] [Abstract][Full Text] [Related]
10. Suppressive effect of selective cyclooxygenase-2 inhibitor on cytokine release in human neutrophils. Kimura T; Iwase M; Kondo G; Watanabe H; Ohashi M; Ito D; Nagumo M Int Immunopharmacol; 2003 Oct; 3(10-11):1519-28. PubMed ID: 12946449 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells. Spinella F; Rosanò L; Di Castro V; Nicotra MR; Natali PG; Bagnato A Clin Cancer Res; 2004 Jul; 10(14):4670-9. PubMed ID: 15269139 [TBL] [Abstract][Full Text] [Related]
12. Involvement of cyclooxygenase-2 in rat models of conjunctivitis. Oka T; Shearer T; Azuma M Curr Eye Res; 2004 Jul; 29(1):27-34. PubMed ID: 15370364 [TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2 inhibitor treatment enhances photodynamic therapy-mediated tumor response. Ferrario A; Von Tiehl K; Wong S; Luna M; Gomer CJ Cancer Res; 2002 Jul; 62(14):3956-61. PubMed ID: 12124326 [TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase isoforms and platelet vessel wall interactions in the apolipoprotein E knockout mouse model of atherosclerosis. Belton OA; Duffy A; Toomey S; Fitzgerald DJ Circulation; 2003 Dec; 108(24):3017-23. PubMed ID: 14638539 [TBL] [Abstract][Full Text] [Related]
15. Selective inhibition of cyclooxygenase-2 enhances platelet adhesion in hamster arterioles in vivo. Buerkle MA; Lehrer S; Sohn HY; Conzen P; Pohl U; Krötz F Circulation; 2004 Oct; 110(14):2053-9. PubMed ID: 15451781 [TBL] [Abstract][Full Text] [Related]
16. Regeneration of megakaryocytopoiesis and thrombopoiesis in vitro from X-irradiated human hematopoietic stem cells. Kashiwakura I; Inanami O; Abe Y; Satoh K; Takahashi TA; Kuwabara M Radiat Res; 2006 Aug; 166(2):345-51. PubMed ID: 16881735 [TBL] [Abstract][Full Text] [Related]
18. Selective COX-2 inhibitor, NS-398, inhibits the replicative senescence of cultured dermal fibroblasts. Han JH; Roh MS; Park CH; Park KC; Cho KH; Kim KH; Eun HC; Chung JH Mech Ageing Dev; 2004 May; 125(5):359-66. PubMed ID: 15130753 [TBL] [Abstract][Full Text] [Related]
19. Ex vivo expansion of human hematopoietic stem cells by a small-molecule agonist of c-MPL. Nishino T; Miyaji K; Ishiwata N; Arai K; Yui M; Asai Y; Nakauchi H; Iwama A Exp Hematol; 2009 Nov; 37(11):1364-1377.e4. PubMed ID: 19744539 [TBL] [Abstract][Full Text] [Related]
20. Expression of cyclooxygenase-2 (COX-2) in human esophageal cancer and in vitro inhibition by a specific COX-2 inhibitor, NS-398. Yu HP; Shi LY; Lu WH; Su YH; Li YY; Xu SQ J Gastroenterol Hepatol; 2004 Jun; 19(6):638-42. PubMed ID: 15151617 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]